La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Apoptosis (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apoptosis < Apoptosis (drug effects) < Apoptosis (genetics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000179 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000260 (2002) Jean Dessolin [France] ; Marie Schuler ; Alice Quinart ; Francesca De Giorgi ; Leon Ghosez ; François IchasSelective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?
000284 (2002) Cristine Alves Da Costa [France] ; Erwan Paitel ; Bruno Vincent ; Frédéric CheclerAlpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease.
000587 (2006) Cristine Alves Da Costa [France] ; Julie Dunys ; Frédéric Brau ; Sherwin Wilk ; Roberto Cappai ; Frédéric Checler6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
000788 (2008) Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette AkwaDisease-modifying drugs and Parkinson's disease.
000F97 (2012) Nigel Ribeiro [France] ; Frédéric Thuaud ; Yohann Bernard ; Christian Gaiddon ; Thierry Cresteil ; Audrey Hild ; Etienne C. Hirsch ; Patrick Pierre Michel ; Canan G. Nebigil ; Laurent DésaubryFlavaglines as potent anticancer and cytoprotective agents.
001440 (2014) Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
001632 (2015) Sonia Lehri-Boufala [France] ; Mohand-Ouidir Ouidja [France] ; Véronique Barbier-Chassefière [France] ; Emilie Hénault [France] ; Rita Raisman-Vozari [France] ; Laure Garrigue-Antar [France] ; Dulce Papy-Garcia [France] ; Christophe Morin [France]New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Apoptosis (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Apoptosis (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Apoptosis (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024